210 related articles for article (PubMed ID: 21153681)
1. Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy.
Joshi S; Ergin A; Wang M; Reif R; Zhang J; Bruce JN; Bigio IJ
J Neurooncol; 2011 Aug; 104(1):11-9. PubMed ID: 21153681
[TBL] [Abstract][Full Text] [Related]
2. The feasibility of real-time in vivo optical detection of blood-brain barrier disruption with indocyanine green.
Ergin A; Wang M; Zhang JY; Bruce JN; Fine RL; Bigio IJ; Joshi S
J Neurooncol; 2012 Feb; 106(3):551-60. PubMed ID: 21964696
[TBL] [Abstract][Full Text] [Related]
3. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
Wang M; Etu J; Joshi S
J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
[TBL] [Abstract][Full Text] [Related]
4. Real-time hemodynamic response and mitochondrial function changes with intracarotid mannitol injection.
Joshi S; Singh-Moon R; Wang M; Bruce JN; Bigio IJ; Mayevsky A
Brain Res; 2014 Feb; 1549():42-51. PubMed ID: 24440631
[TBL] [Abstract][Full Text] [Related]
5. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chun TW; Liu X; Weiss HR
Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
[TBL] [Abstract][Full Text] [Related]
6. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
7. Technique of, and complications attributable to, repeated hyperosmotic blood-brain barrier disruption in dogs.
Culver B; Inzana K; Jones J; Troy G; Kroll R; Culver B; Jortner B
Am J Vet Res; 1998 Nov; 59(11):1503-10. PubMed ID: 9829415
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
9. Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain.
Chen KB; Wei VC; Yen LF; Poon KS; Liu YC; Cheng KS; Chang CS; Lai TW
Neuroreport; 2013 Apr; 24(6):303-7. PubMed ID: 23426109
[TBL] [Abstract][Full Text] [Related]
10. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate.
Sage MR; Wilcox J; Evill CA; Benness GT
Invest Radiol; 1982; 17(3):276-81. PubMed ID: 6811497
[TBL] [Abstract][Full Text] [Related]
11. Effects of nitric oxide on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chang Q; Wang G; Weiss HR
Anesth Analg; 1997 Feb; 84(2):370-5. PubMed ID: 9024031
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption.
Foley CP; Rubin DG; Santillan A; Sondhi D; Dyke JP; Crystal RG; Gobin YP; Ballon DJ
J Control Release; 2014 Dec; 196():71-78. PubMed ID: 25270115
[TBL] [Abstract][Full Text] [Related]
13. The effects of morphine on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lee DI; Liu X; Weiss HR
Anesth Analg; 2000 Mar; 90(3):603-8. PubMed ID: 10702444
[TBL] [Abstract][Full Text] [Related]
14. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
[TBL] [Abstract][Full Text] [Related]
15. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema.
Inoue T; Nagara H; Kondo A; Fukui M; Tateishi J
Brain Res; 1987 Jun; 414(2):309-13. PubMed ID: 3113663
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lu X; Wei HM; Williams JA; Weiss HR
Anesth Analg; 1996 Aug; 83(2):336-41. PubMed ID: 8694315
[TBL] [Abstract][Full Text] [Related]
17. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. An electron microscopic study.
Salahuddin TS; Johansson BB; Kalimo H; Olsson Y
Acta Neuropathol; 1988; 77(1):5-13. PubMed ID: 3149121
[TBL] [Abstract][Full Text] [Related]
18. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
Kozler P; Pokorný J
Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531
[TBL] [Abstract][Full Text] [Related]
19. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.
Yang W; Barth RF; Carpenter DE; Moeschberger ML; Goodman JH
Neurosurgery; 1996 May; 38(5):985-92. PubMed ID: 8727825
[TBL] [Abstract][Full Text] [Related]
20. A new method of quantitatively assessing the opening of the blood-brain barrier in murine animal models.
Blanchette M; Michaud K; Fortin D
J Neurosci Methods; 2012 Jun; 207(2):125-9. PubMed ID: 22521326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
